863 filings
Page 2 of 44
SC 13G
CYCC
Cyclacel Pharmaceuticals Inc
10 Jan 24
Cyclacel Pharmaceuticals / Altium Capital Management ownership change
1:35pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
8 Jan 24
Regulation FD Disclosure
5:45pm
SC 13G
Lind Global Fund II LP
4 Jan 24
Cyclacel Pharmaceuticals / Lind Global Fund II ownership change
4:30pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
4 Jan 24
Other Events
4:05pm
4
CYCC
Cyclacel Pharmaceuticals Inc
26 Dec 23
Cyclacel Pharmaceuticals / Paul McBarron ownership change
4:05pm
4
Spiro George Rombotis
26 Dec 23
Cyclacel Pharmaceuticals / Spiro George Rombotis ownership change
4:05pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
26 Dec 23
Cyclacel Pharmaceuticals Announces Registered Direct and Private Placement Offering Priced At-The-Market Under Nasdaq Rules
9:29am
424B5
CYCC
Cyclacel Pharmaceuticals Inc
26 Dec 23
Prospectus supplement for primary offering
9:28am
8-K
CYCC
Cyclacel Pharmaceuticals Inc
12 Dec 23
Submission of Matters to a Vote of Security Holders
4:06pm
10-Q
2023 Q3
CYCC
Cyclacel Pharmaceuticals Inc
Quarterly report
28 Nov 23
9:31pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
28 Nov 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:59pm
NT 10-Q
CYCC
Cyclacel Pharmaceuticals Inc
15 Nov 23
Notice of late quarterly filing
5:04pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
15 Nov 23
Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
5:03pm
DEF 14A
CYCC
Cyclacel Pharmaceuticals Inc
Definitive proxy
14 Nov 23
4:30pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
13 Nov 23
Cyclacel Pharmaceuticals Reports THIRD quarter financial results
4:06pm
8-K
CYCC
Cyclacel Pharmaceuticals Inc
7 Nov 23
Amendments to Articles of Incorporation or Bylaws
4:10pm
PRE 14A
CYCC
Cyclacel Pharmaceuticals Inc
Preliminary proxy
2 Nov 23
4:30pm
EFFECT
CYCC
Cyclacel Pharmaceuticals Inc
14 Sep 23
Notice of effectiveness
12:15am
CORRESP
CYCC
Cyclacel Pharmaceuticals Inc
11 Sep 23
Correspondence with SEC
12:00am